Flynn James E

EDGAR CIK 0001352546

Nuvalent, Inc. - NUVL

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner Other owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($35.44) M
-371,287 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/24/2025
11/24/2025
Sell
-371,287 @ $95.44
 ($35,437,488) 8,299,225 (-4.28%) Indirect - Through Deerfield Private Design Fund IV, L.P.

Larimar Therapeutics, Inc. - LRMR

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner Other owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
3
$30.00 M
9,375,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/31/2025
08/04/2025
Buy
3,387,529 @ $3.20
 $10,840,093 9,538,918 (55.07%) Indirect - Through Deerfield Private Design Fund III, L.P.
07/31/2025
08/04/2025
Buy
3,387,539 @ $3.20
 $10,840,125 9,538,945 (55.07%) Indirect - Through Deerfield Private Design Fund IV, L.P.
07/31/2025
08/04/2025
Buy
2,599,932 @ $3.20
 $8,319,782 7,321,129 (55.07%) Indirect - Through Deerfield Healthcare Innovations Fund, L.P.

ARS Pharmaceuticals, Inc. - SPRY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
2
($13.66) M
-740,149 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/27/2025
07/01/2025
Sell
-370,075 @ $18.46
 ($6,831,584) 4,887,254 (-7.04%) Indirect - Through Deerfield Private Design Fund III, L.P.
06/27/2025
07/01/2025
Sell
-370,074 @ $18.46
 ($6,831,566) 4,887,254 (-7.04%) Indirect - Through Deerfield Private Design Fund IV, L.P.